Journal of Virology, May 2001, p. 4614-4624, Vol. 75, No. 10
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4614-4624.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Institute for Virology, Johannes-Gutenberg University Mainz, 55131 Mainz, Germany
Received 21 December 2000/Accepted 21 February 2001
| |
ABSTRACT |
|---|
|
|
|---|
Studies of the Hepatitis C virus (HCV) replication cycle have been made possible with the development of subgenomic selectable RNAs that replicate autonomously in cultured cells. In these replicons the region encoding the HCV structural proteins was replaced by the neomycin phosphotransferase gene, allowing the selection of transfected cells that support high-level replication of these RNAs. Subsequent analyses revealed that, within selected cells, HCV RNAs had acquired adaptive mutations that increased the efficiency of colony formation by an unknown mechanism. Using a panel of replicons that differed in their degrees of cell culture adaptation, in this study we show that adaptive mutations enhance RNA replication. Transient-transfection assays that did not require selection of transfected cells demonstrated a clear correlation between the level of adaptation and RNA replication. The highest replication level was found with an adapted replicon carrying two amino acid substitutions located in NS3 and one in NS5A that acted synergistically. In contrast, the nonadapted RNA replicated only transiently and at a low level. The correlation between the efficiency of colony formation and RNA replication was corroborated with replicons in which the selectable marker gene was replaced by the gene encoding firefly luciferase. Upon transfection of naive Huh-7 cells, the levels of luciferase activity directly reflected the replication efficiencies of the various replicon RNAs. These results show that cell culture-adaptive mutations enhance HCV RNA replication.
| |
INTRODUCTION |
|---|
|
|
|---|
The Hepatitis C virus (HCV) is one of the most common etiologic agents of chronic liver diseases (reviewed in reference 37). Acute infections are usually subclinical or associated with mild symptoms, but the virus persists in more than 70% of infected individuals. The long-term outcomes of these persistent infections are varied, and they can range from an apparently healthy carrier state to chronic active hepatitis, liver fibrosis, cirrhosis, and eventually hepatocellular carcinoma.
HCV was classified in the genus Hepacivirus of the family Flaviviridae, to which the genera Flavivirus (with the prototype member Yellow fever virus) and Pestivirus (with the representative member Bovine viral diarrhea virus) belong (33). These viruses have enveloped particles that harbor an RNA genome of positive polarity. The HCV genome has a length of about 9,600 nucleotides, and it carries a single long open reading frame (ORF) that is flanked at both termini by nontranslated regions (NTRs). Viral proteins are generated as a polyprotein precursor that is translated via the internal ribosome entry site (IRES) located in the 5' NTR (45, 47). It permits the direct binding of the 40S ribosome subunit in the absence of additional translation factors (35). The polyprotein precursor is cleaved by viral and host cell enzymes into at least 10 different products (for recent reviews, see references 2 and 39). The structural proteins that are located in the amino-terminal region of the polyprotein are the core protein and the envelope glycoproteins E1 and E2 (22). The nonstructural proteins NS2, NS3, NS4A, NS4B, NS5A, and NS5B are separated from the structural proteins by the short hydrophobic polypeptide p7, which has an unknown function (27, 32). NS2 and the amino-terminal region of NS3 constitute the NS2-3 proteinase responsible for cleavage at the NS2/3 site (19, 21). Three enzymatic activities reside in NS3: a serine-type proteinase in the ~180 amino-terminal residues and nucleoside triphosphatase- helicase activities that are located in the remainder of the protein (3, 20, 26, 41, 44). NS4A is an essential cofactor of the NS3 proteinase that forms a stable heterodimeric NS3-NS4A complex that mediates cleavages at the NS3/4A, NS4A/B, NS4B/5A, and NS5A/B sites (4, 14, 28, 42). The function of NS4B is not known. NS5A is a highly phosphorylated polypeptide that may be involved in resistance to the antiviral activity of alpha interferon (12, 13, 16, 17). Phosphorylation is mediated by an as yet unknown cellular kinase (23, 40, 43). A major phosphoacceptor site has been mapped for a genotype 1a isolate, but this site is not conserved with NS5A proteins of other HCV genotypes (38). Most HCV isolates contain two phosphoprotein variants with apparent molecular masses of 56 and 58 kDa corresponding to the basal and the hyperphosphorylated forms, respectively (25, 40, 43). It is not known whether NS5A has a direct role in RNA replication and whether phosphorylation is important for its function(s). NS5B is the RNA-dependent RNA polymerase (RdRp) (5, 31, 48).
The development of selectable subgenomic HCV replicons for the first
time enabled the study of viral RNA replication in cell culture
(30). These replicons are composed of the 5' NTR, which directs translation of the gene encoding the neomycin
phosphotransferase; the IRES of the Encephalomyocarditis
virus (EMCV), which directs translation of the HCV NS3-NS5B
region; and the 3' NTR (Fig. 1). Upon
transfection of cells of the human hepatoma cell line Huh-7 and
selection with G418, cell lines that carried high levels of self-replicating HCV RNAs could be established. Subsequent analyses of
the sequences of HCV RNAs isolated from selected cell lines revealed
that these replicons harbored cell culture-adaptive mutations (6,
29). For instance, a single amino acid substitution in the NS5B
RdRp increased the efficiency of colony formation (ECF) ~500-fold
compared with that of the unaltered replicon RNA (29). However, the mechanism by which this cell culture adaptation was achieved remained unknown. In this study we show that cell
culture-adaptive mutations enhance RNA replication. Using a
transient-transfection assay without subsequent selection of cells, we
demonstrate a clear correlation between the level of cell culture
adaptation and RNA replication. However, within selected cell lines
that were obtained after transfection of replicons with different
levels of adaptation, the differences in the replicon copy numbers per cell varied only slightly. These results suggest that the host cell
plays an additional important role in determining the replication level.
|
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell cultures. Cell monolayers of the human hepatoma cell line Huh-7 (34) were routinely grown in Dulbecco's modified minimal essential medium (DMEM; Life Technologies, Karlsruhe, Germany) supplemented with 2 mM L-glutamine, nonessential amino acids, 100 U of penicillin, 100 µg of streptomycin, and 10% fetal calf serum. G418 (Geneticin; Life Technologies) was added at a final concentration of 500 to 1,000 µg/ml to cell lines carrying HCV replicons.
Plasmid constructions.
All nucleotide numbers refer to a
complete HCV genome cloned by our group (EMBL database accession number
AJ238799). Construction of the vector pFK and the parental replicon
construct pFK-I389neo/NS3-3'/wt (EMBL database accession
number AJ242654) has been described recently (29, 30). To
analyze adapted replicon variants from cell line 5-15-9-2-3 for
functionality, SfiI-restricted DNA fragments (nucleotides
[nt] 3622 to 8499) that were generated by long-distance reverse
transcription PCR (RT-PCR) were transferred into the parental replicon
pFK-I389neo/NS3-3'/wt. These constructs were designated 5.1 to 5.16 and 1 to 66. Of the four clones with the highest ECFs (5.1, 5.2, 5.16, and 19), the HCV sequence between the two SfiI sites was determined, and with clone 5.1, each mutation leading to an
amino acid substitution was introduced individually into the parental
replicon. Plasmids pFK2109 Asn
Asp and pFK2197 Ser
Pro were
generated by transferring MluI-EcoRI (nt 6529 to 6699) and EcoRI-XhoI (nt 6699 to 7186) fragments,
respectively, from pFK5.1 into pFK-I389neo/NS3-3'/wt. To
obtain plasmid pFK1202 Glu
Gly/1280 Thr
Ile, which harbors both
NS3 mutations, a PmeI-BstXI fragment (5' end of
the EMCV IRES up to nt 4319) from pFK5.1 was transferred into the
parental replicon construct. These two mutations were separated by
transferring a PmeI-EagI (nt 3991) or an
EagI-EcoRI fragment that was obtained from this
construct into the parental replicon, resulting in plasmid pFK1202 Glu
Gly or pFK1280 Thr
Ile, respectively. Plasmid pFK1757 Leu
Ile was generated by transferring a SalI-MluI
fragment (nt 4725 to 6529) into pFK-I389neo/NS3-3'/wt. To
obtain plasmids pFK2327 Pro
Ser and pFK2350 Lys
Glu,
XhoI-PshAI (nt 7186 to 7338) and
MluI-SpeI fragments (nt 6529 up to the 3' end of
the HCV sequence), respectively, were inserted into the parental
replicon construct. Combinations of individual NS3 mutations with the
major adaptive mutation in NS5A (2197 Ser
Pro) were obtained by
transferring the EcoRI-XhoI fragment from pFK2197
Ser
Pro into pFK1202 Glu
Gly or pFK1280 Thr
Ile. The
presence of each mutation was confirmed by sequence analysis. To
generate the corresponding luciferase plasmids for the
transient-replication assay, the neo gene was replaced by
the gene encoding the luciferase of the firefly Photinus
pyralis by using the AscI and PmeI
restriction sites. These sites were introduced at the 5' and 3' ends of
the luciferase gene by PCR.
Preparation of total RNA and quantification of HCV RNA by
Northern blotting.
The methods to prepare total RNA and quantify
HCV RNA by Northern blotting have been described recently
(29). In brief, total RNA was prepared by a single-step
isolation method (8), denatured by treatment with 5.9%
glyoxal in a solution containing 50% dimethyl sulfoxide and 10 mM
sodium phosphate buffer (pH 7.0), and analyzed after denaturing agarose
gel electrophoresis by Northern blotting. Prior to hybridization, the
membrane was stained with methylene blue and cut ~1 cm below the 28S
rRNA band and the upper strip containing the HCV replicon RNA was
hybridized with a 32P-labeled negative-sense riboprobe
complementary to the 3' end of the NS5B region and part of the 3' NTR
(nt 8362 to 9408). The lower strip that was hybridized with a
-actin-specific antisense riboprobe was used to correct for total
RNA amounts loaded in each lane of the gel. Specific bands were
quantitated by phosphorimaging with a BAS 2500 scanner (Fuji), and the
number of replicon molecules was determined by comparison with a serial
dilution of in vitro transcripts loaded in parallel onto the gel.
Determination of the copy number of replicon RNAs. Owing to the dependence of RNA replication on host cell proliferation (36), copy numbers could not be determined from single measurements. Therefore, 5 × 105 cells that had been regularly passaged three times a week at a dilution of 1:3 to 1:5 in the presence of 500 µg of G418 per ml were seeded in a 6-cm-diameter cell culture dish and harvested at daily intervals 3 to 6 days after seeding. The amounts of replicon RNA were determined by Northern blotting analysis as described above. For each replicon, at least three independent cell lines were examined.
Amplification of replicon RNA by RT-PCR and cloning of amplified DNA fragments. Amplification of replicon RNAs was done by long-distance RT-PCR using a mixture of polymerases (7). One microgram of total RNA and 50 pmol of primer A9413 (CAG GAT GGC CTA TTG GCC TGG AG) were mixed in a total volume of 10.5 µl and denatured for 10 min at 65°C. Reverse transcription was performed with Expand-RT (Roche Biochemicals, Mannheim, Germany) in a total volume of 20 µl, and after 1 h at 42°C, different amounts of the reaction mixture were used for PCR with the Expand Long Template PCR system (Roche Biochemicals) and primers S59 (TGT CTT CAC GCA GAA AGC GTC TAG) and A9386 (TTA GCT CCC CGT TCA TCG GTT GG). Cycle conditions were two min of initial denaturation at 94°C and 40 cycles of 10 s at 94°C, 90 s at 54°C, and 540 s at 68°C. After 10 cycles, the extension time was increased 10 s for each additional cycle. After a final 10-min incubation at 68°C, PCR products were purified by preparative agarose gel electrophoresis, restricted with SfiI, and inserted into the parental construct pFK-I389neo/NS3-3'/wt.
Sequence analysis. Sequences were verified using the Thermo Sequenase Fluorescently Labeled Primer Cycle Sequencing kit with 7-deaza-dGTP (Amersham Pharmacia Biotech, Freiburg, Germany) and IRD-41-labeled primers (MWG-Biotech, Ebersberg, Germany) according to the instructions of the manufacturer. Reaction mixtures were analyzed on a model 4000 Licor DNA sequencer (MWG-Biotech).
In vitro transcription, electroporation, and selection of G418-resistant cell lines. In vitro transcripts were generated using the protocol described recently (29). In brief, plasmid DNA was restricted with AseI and ScaI (New England Biolabs, Bad Schwalbach/Taunus, Germany) and after extraction with phenol and chloroform and precipitation with ethanol dissolved in RNase-free water. In vitro transcription reaction mixtures contained 80 mM HEPES (pH 7.5), 12 mM MgCl2, 2 mM spermidine, 40 mM dithiothreitol (DTT), 3.125 mM each nucleoside triphosphate, 1 U of RNasin (Promega, Mannheim, Germany) per µl, 0.1 µg of restricted plasmid DNA per µl, and 0.6 U of T7 RNA polymerase (Promega) per µl. After 2 h at 37°C, an additional 0.3 U of T7 RNA polymerase per µl was added and the reaction mixture was incubated for another 2 h. Transcription was terminated by the addition of 1.2 U of RNase-free DNase (Promega) per µg of plasmid DNA and 30 min of incubation at 37°C. After one extraction with acidic phenol and chloroform, DNA was precipitated with isopropanol and dissolved in RNase-free water. The concentration was determined by measurement of the optical density at 260 nm, and RNA integrity was checked by denaturing agarose gel electrophoresis. The conditions for electroporation and selection of G418-resistant cells have been described in detail elsewhere (29). Briefly, 0.25 to 500 ng of in vitro transcripts adjusted with total RNA from naïve Huh-7 cells to a final amount of 10 µg was mixed with 400 µl of a suspension of 107 Huh-7 cells per ml. Electroporation conditions were 960 µF and 270 V using a Gene pulser system (Bio-Rad, Munich, Germany) and a cuvette with a gap width of 0.4 cm (Bio-Rad). Cells were immediately transferred to 8 ml of complete DMEM containing 1.25% dimethyl sulfoxide and seeded in a 10-cm-diameter cell culture dish. After 24 h, medium was replaced by complete DMEM supplemented with 500 µg of G418 per ml. Medium was changed weekly, and 3 to 4 weeks after electroporation, colonies were stained with Coomassie brillant blue (0.6 g/liter in 50% methanol-10% acetic acid). To determine the number of CFU of a given RNA, serial dilutions from 300 to 0.25 ng of RNA were transfected into Huh-7 cells and processed further as described above. For each replicon, 5 to 20 independent transfections were performed.
Transient-replication assays. Huh-7 cells were transfected by electroporation as described above using 7.5 µg of a neo replicon or 5 µg of a luciferase replicon. After addition of 10 ml of complete DMEM, 1- to 2-ml aliquots of the cell suspension were seeded in a 3-cm-diameter culture dish and harvested at time points given in Results. For Northern blot analysis, total RNA was analyzed as described above. With luciferase replicons, cells were washed three times with phosphate-buffered saline (PBS) and scraped off the plate into 350 µl of ice-cold lysis buffer (1% Triton X-100, 25 mM glycylglycine, 15 mM MgSO4, 4 mM EGTA, 1 mM DTT). One hundred microliters of lysate was mixed with 360 µl of assay buffer (25 mM glycylglycine, 15 mM MgSO4, 4 mM EGTA, 1 mM DTT, 2 mM ATP, 15 mM K2PO4 [pH 7.8]) and, after addition of 200 µl of a 200 µM luciferin stock solution, measured in a luminometer (Lumat LB9507 from Berthold, Freiburg, Germany) for 20 s. Values obtained with cells harvested 4 h after electroporation were used to determine the transfection efficiency.
Immunofluorescence.
Transfected cells (0.7 × 105) were seeded on glass coverslips and, after 4, 15.5, 24, 48, 72, and 96 h, washed three times with PBS. Cell were fixed
in an ice-cold mixture of acetone and methanol (90 and 10%) for about
10 min at
20°C and washed thereafter three times with PBS, followed
by a 1-h incubation in IF buffer (PBS, 3% bovine serum albumin, 0.1%
Triton X-100) at 4°C. An NS3B-specific rabbit polyclonal antibody
(3) was added at a dilution of 1:500 in IF buffer, and
after 1 h, cells were washed three times with PBS, followed by
incubation with a 1:100 dilution of an anti-rabbit antibody conjugated
with fluorescein isothiocyanate (Sigma, Deisenhofen, Germany) in IF
buffer. Coverslips were washed with PBS and mounted on glass slides
with Permafluor (Immunotech, Marseille, France), and cells were
examined under a fluorescence microscope (Zeiss, Jena, Germany).
| |
RESULTS |
|---|
|
|
|---|
Construction of a cell culture-adapted HCV replicon RNA.
To
study the mechanism of cell culture adaptation, a highly efficient
replicon RNA was required. Although we had recently identified a single
amino acid substitution in NS5B that increased the ECF ~500-fold
(29), we attempted to develop an even more efficient
replicon. On the assumption that adaptive mutations might accumulate
during serial passage of replicon RNAs, total RNA was isolated from a
cell line that harbored an NS3-5B replicon (cell line 5-15 [30]) and transfected into naïve Huh-7 cells. After stringent selection with 1 mg of G418 per ml, a fast-growing cell
clone was isolated and total RNA was prepared and transfected into
parental Huh-7 cells. After three successive passages, cell line
5-15-9-2-3 was obtained. To identify cell culture-adaptive mutations,
nearly full-length replicon RNAs were amplified by long-distance RT-PCR
using primers S59 and A9386 and, after restriction of the amplified DNA
fragments with SfiI, almost the complete HCV ORF was
inserted into the parental replicon construct (Fig. 1). In vitro
transcripts from 82 different clones were prepared and transfected into
naïve Huh-7 cells to determine their ECFs. As summarized in
Table 1, 69 clones were replication
defective, because no G418-resistant colonies were obtained. Nine of
the tested clones were comparable to the wild type (20 to 50 colonies), whereas four clones were more efficient. The sequence analysis of the
SfiI fragments of these clones revealed several amino acid substitutions (Fig. 1). Six of them were found in all four clones derived from the cell line 5-15-9-2-3, whereas the number of
nonconserved amino acid substitutions was variable. A careful titration
of in vitro transcripts derived from the two most efficient clones, which were designated 5.1 and 19, revealed that replicon 5.1 had the
highest ECF (~500,000 CFU per µg of RNA) and that replicon 19 was
about sevenfold less efficient (~70,000 CFU/µg).
|
Determination of adaptive mutations in the HCV coding
sequence.
Since adaptive mutations should be generated early
during selection and become fixed in all RNA progeny, we focused our
further analyses on the conserved amino acid substitutions. Three of
these six substitutions were located in NS5A, and two were located in NS3. Only one conserved mutation was found in NS4B, and none were found
in NS4A and NS5B (see below). Interestingly, the conserved mutation in
the center of NS5A at position 2197 of the HCV polyprotein was also
present in two clones that were isolated from the founder cell line
5-15 (Fig. 1). In contrast, a second conserved substitution in NS5A at
position 2350 was found in only one of these two clones (5-15/4B). To
identify which of the six conserved mutations were responsible for cell
culture adaptation, they were introduced individually into the parental
replicon construct and serial dilutions of in vitro transcripts were
transfected into naïve Huh-7 cells. After selection with G418,
the ECF was determined. The results shown in Fig.
2 demonstrate that the most adaptive
mutation was the one located in the center of NS5A at amino acid
position 2197 of the polyprotein. In addition, the glycine substitution
for glutamic acid and the isoleucine substitution for threonine in NS3
at positions 1202 and 1280, respectively, increased the ECF too, albeit
to a much lesser extent. All other mutations did not affect the number
of G418-resistant cell colonies. Interestingly, the highly adaptive
NS5A substitution, but not the NS3 mutations, was already found in the
replicons isolated from the founder cell line 5-15. Thus, the initial
adaptive mutation was the one found in NS5A, and this mutation remained
conserved during cell culture passage of the replicon RNAs. The
additional adaptive mutations in NS3 must have been acquired at a later
stage or were present only in a minor fraction of replicons in the
founder cell line and accumulated during successive cell culture
passage. Owing to the high selective pressure we used, the presence of
these three mutations in the replicon RNA appeared to confer a
selection advantage. In agreement with this assumption, we found that
these substitutions were synergistic. When the two NS3 mutations were combined, the ECF of the replicon was ~4-fold higher than that of the
RNA harboring only the adaptive substitution at position 1280. However,
when both NS3 mutations were combined with the adaptive NS5A
substitution at position 2197, the ECF of the triple mutant was
dramatically increased compared with the replicon that harbored only
this NS5A substitution (Fig. 2). In fact, the G418 transduction
efficiency of the triple mutant was as high as the one obtained with
replicon 5.1. Since the analysis of sequences of the HCV ORF flanking
the SfiI fragment did not reveal additional amino acid
substitutions in NS3 and NS5B that were conserved between the four
replicons recloned from cell line 5-15-9-2-3, we had identified the
major adaptive mutations.
|
Transient replication of HCV RNAs in nonselected cells.
In all
experiments performed so far we had measured RNA replication by
determining the G418 transduction efficiency. Since this approach did
not allow the direct determination of replication kinetics,
transient-replication assays in nonselected cells were performed. For
this approach we chose the most adapted RNAs, 5.1 and 19, and replicon
9-13F, which had an ECF that was ~100-fold lower than that of RNA 5.1 (Table 2). Replicon 9-13F carried one
essential adaptive mutation in NS5A at position 2163 of the polyprotein
(29). A derivative of replicon 5.1 that carried a
10-amino-acid residue deletion spanning the active site of the NS5B
RdRp served as a negative control (rep5.1/
5B) (Fig.
3A). Huh-7 cells were transfected with
these neo replicons, and total RNA that was prepared after
3.5, 15, 24, 48, 72, and 96 h was analyzed by Northern blotting to
determine the copy numbers of the replicons. The representative result
in Fig. 3A shows that input RNA was rapidly degraded and barely
detectable 15 h after transfection (lane 28). In the low-level
adaptation replicon 9-13F, a much slower gradual reduction of HCV RNA
could be observed, and it became undetectable at 96 h
posttransfection (lanes 21 to 26). In contrast, an increase of the copy
numbers of HCV RNAs was found with the two highly adapted replicons. A
careful quantification of the Northern blot by phosphorimaging revealed
that the copy numbers of both RNAs increased 24 h after
transfection (Fig. 3B), which is the time when transfected cells
started growing. In replicon 5.1, at 72 h posttransfection the
level of replicating RNA reached a maximum and declined within the next
24 h, when cells became confluent. A similar kinetic was found with
replicon 19, but the copy number at the time of the peak was ~3-fold
lower. As described above, the decline in the amounts of replicon RNAs
in confluent cells (96 h) was most likely due to the tight linkage
between RNA replication and host cell proliferation (36).
|
|
|
Transient replication of HCV replicons carrying a luciferase
reporter gene.
To further substantiate this assumption and to
simplify the subsequent analyses, we replaced the neo genes
in the various cell culture-adapted replicons by the gene encoding the
luciferase of the firefly P. pyralis (Fig.
5A). Since the copy number of this
reporter gene should be determined by the replication levels of the
corresponding replicon RNAs, the luciferase activity in a lysate of
transfected cells could be used to directly monitor the replication of
an RNA. Huh-7 cells were transfected by electroporation, and each 1/10
of the cells was seeded into a cell culture dish. Cells were harvested
at various time points, and luciferase activities were determined. As a
negative control, a derivative of the wild-type replicon that carried a
single amino acid substitution changing the GDD motif of the RdRp
active site to GND was transfected in parallel. Luciferase activities
measured 4 h after transfection were used to determine the
transfection efficiencies. A representative result is shown in Fig. 5.
In this experiment we also analyzed the replication of the HCV RNAs in
cells after passage, because we wanted to avoid the reduction of
replicon RNA levels when the cells reached confluence
(36). Therefore, cells in one culture dish were passaged
at a dilution of 1:3 at 72 h posttransfection and passaged a second
time 96 h later (Fig. 5B). Cells were harvested at given time
points to determine the luciferase activities. Overall, the replication
kinetics observed with these luciferase replicons were very
similar to the ones obtained with the neo replicons that
were analyzed by Northern blot analysis up to 96 h after transfection (Fig. 5C). At every determined time point (except 4 h
posttransfection), luciferase activities obtained with the most highly
adapted RNA, 5.1, were consistently the highest whereas those found in
9-13F-transfected cells were much lower. Interestingly, in the cells
passaged at 72 h posttransfection, an increase in luciferase
activity was clearly visible with replicons 5.1, 19, and 9-13F (compare
the values obtained 127 and 144 h posttransfection). When these
cells were passaged a second time 96 h after the first passage,
only in cells transfected with the highly adapted replicons 5.1 and 19 could a second increase of luciferase activity be observed (compare the
values at 216 and 244 h posttransfection). These results show
that, in unselected cells, the replicons were gradually lost, with the
level of decline being determined by the level of cell culture
adaptation.
|
P)
were higher. When these two mutations were combined, the resulting RNA
replicated at a level that was clearly higher than the sum of the
replication levels of the RNAs carrying the substitutions individually.
A further increase was found with the replicon harboring in addition
the substitution in NS3 at position 1280. Although this mutation, when
analyzed individually, only slightly increased replication compared
with that of the nonadapted replicon, it did so synergistically both in
combination with the other more adaptive NS3 substitution at position
1202 and with the adaptive NS5A mutation at position 2197. In fact, the
replication level of this triple mutant was as high as the one observed
with replicon 5.1, confirming that these NS3 and NS5A substitutions
were responsible for cell culture adaptation and enhanced replication
levels synergistically. In summary, the results that were based on
luciferase HCV replicons correlated well with the results
obtained with the neo replicons, both in transient-replication assays and after selection of stable cell lines.
Thus, HCV RNAs that harbor a reporter gene can be used to accurately
determine replication of the replicon RNA.
|
Lack of correlation between the ECF and replicon RNA copy number in
G418-selected cell lines.
To analyze whether an increase in the
ECF and the RNA replication level would directly correlate with the
copy number of an HCV RNA in a selected cell line, we took advantage of
several HCV replicons that differed in their levels of cell culture
adaptation. Replicons 5.1, 19, and 9-13F were the ones described above.
Replicon 5B2884Gly harbored a single glycine substitution in NS5B at
position 2884 that led to an ~500-fold increase in the ECF compared
with that of the wild type (29) (Table 2). In vitro
transcripts of these constructs were transfected into naïve
Huh-7 cells, and for each replicon at least three cell clones were
isolated and expanded. To determine the copy numbers of these RNAs in
selected cells, we had to consider that the replication levels of the
replicons depend on host cell metabolism (36). Therefore,
copy numbers were determined from serial measurements using cells that
had been harvested 3, 4, 5, and 6 days after seeding. A representative example of this analysis is shown in Fig.
7 for three different cell lines that
were obtained after transfection with the most highly adapted replicon,
5.1, and a summary for all cell lines is given in Table 2. In agreement
with the ECFs, the highest copy number was found in cell lines
harboring replicon 5.1. However, in spite of the dramatic differences
in the numbers of colonies obtained with a given replicon RNA, the
replication levels within a selected cell line differed much less. Even
between the replicons with the highest and the lowest levels of
adaptation (5.1 and 9-13F, respectively), which varied in their ECFs by
a factor of ~100, the differences in the copy numbers were only
~2-fold. With the other replicons, the replication levels were
comparable. This result suggests that the ECF is primarily determined
by the initial level of RNA replication and that, during selection,
either particular host cells that support high-level replication of the
HCV RNA are enriched or further adaptive mutations are acquired.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study we developed a novel highly adapted HCV replicon that harbors two synergistic mutations in NS3 and one in NS5A. The ECF of this RNA was ~5 × 105 CFU per µg of RNA, which is ~20-fold higher than that of the best-adapted replicon we described recently (29). By analyzing this and several other HCV RNAs that differed with respect to their levels of cell culture adaptation, we found a clear correlation between the ECF and RNA replication as determined by two different transient-transfection assays. These results demonstrate that cell culture-adaptive mutations increase RNA replication. They also provide an explanation of how adaptive replicons are generated. As shown with the parental replicon carrying the luciferase gene, this nonadapted RNA replicated only transiently and at a low level in transfected cells. During this time, mutations must have been generated by the viral RNA polymerase that in a few instances were adaptive. By increasing the level of RNA replication, cells harboring such a replicon developed G418 resistance. Since most mutations did not increase but rather reduced replication or were inactivating, development of an adaptive replicon was a rare event, explaining why the numbers of G418-resistant colonies that were obtained with a nonadapted RNA were very low. Alternatively, the adaptive mutations may have been introduced by the T7 RNA polymerase used for in vitro transcription. However, given the infrequent generation of adaptive mutations, the number of replication-competent RNA molecules in the transcription reaction probably would have been too low to allow detection in the luciferase assay. The fact that we consistently observed a low level of replication with the parental replicon suggests that the adaptive mutations were generated during the initial low-level replication of this RNA.
While a clear correlation was found between replication in the transient-transfection assays and the ECF, this was not the case with respect to the copy number of replicon RNA molecules per cell after selection. For instance, the most highly adapted replicon, 5.1, had an ECF of ~5 × 105 CFU/µg of RNA and showed the highest initial replication whereas the ECF of the least-adapted replicon was ~100-fold lower, and this RNA replicated very inefficiently. However, in selected cell lines obtained after transfection with these replicon RNAs, the copy numbers differed only by a factor of ~2. This result indicates that during selection of cells harboring a poorly adapted replicon, further mutations that increase the replication level are introduced into the RNA. Alternatively, during prolonged passage, we may have selected for particular host cells that support high-level replication. Currently, we cannot distinguish between the two possibilities, but in agreement with the latter assumption, we found that the copy number of replicon RNA was highest in cell line 9-13 (2.5 × 108 per µg of total RNA), which harbored a moderately adapted replicon (rep5B2884Gly with a substitution in NS5B that increased the ECF ~500-fold over the wild-type level) (29). In contrast, in cell line 5-15-9-2-3 carrying the most highly adapted replicon (rep5.1 with an ECF that is ~10,000-fold higher than that of the wild type), the replicon copy number was even lower (1.6 × 108 per µg of total RNA). Therefore, the level of cell culture adaptation is determined by the initial replication level, which also determines the level of G418 transduction efficiency. However, during prolonged cell passage and selection, particular host cells that support a higher level of replicon RNA replication may be selected.
By serial cell culture passage of replicon RNAs, we selected for three mutations that enhanced replication synergistically. In the founder cell line, only the highly adaptive substitution in NS5A was found, and it was the only conserved mutation in the two analyzed clones. Thus, the initial adaptation was due to this particular substitution whereas the adaptive mutations in NS3 were generated at a later stage during cell culture passage. Alternatively, these NS3 substitutions might have already been present at a low frequency in the replicons of the founder cell line but were enriched by the stringent selection procedure.
Currently, we can only speculate about the molecular mechanism of cell culture adaptation. There are certainly several ways how it can be achieved. In a previous study we had shown that a single amino acid substitution in NS5B increased the ECF ~500-fold compared to that of the parental RNA (29). In this report, we identified two substitutions in NS3 and one in the center of NS5A. Three-dimensional structure modeling experiments suggest that the substitution at the carboxy terminus of NS3 (position 1202) is located on the surface of the molecule and probably has no effect on its various enzymatic activities (Neera Borkakoti, personal communication). The same is probably true for the mutation in domain 1 of the NS3 helicase at position 1280. We therefore favor the hypothesis that these amino acid changes affect an interaction site with a cellular or viral protein important for RNA replication. With NS5A, the substitution affected serine 2197, and this residue was shown to be important for hyperphosphorylation (43). The loss of this serine residue in the adapted replicon RNA may suggest that phosphorylation at this position is inhibitory for RNA replication. However, it is not known whether serine 2197 is a phosphoacceptor site or plays some other role in hyperphosphorylation. As deduced from the formation of pp58, the NS5A in cells harboring replicon 5.1 is still hyperphosphorylated (N. Krieger and R. Bartenschlager, unpublished results). However, the appearance of the pp56/58 double band in conventional sodium dodecyl sulfate-polyacrylamide gel electrophoresis may not be sufficient to reveal subtle differences in the phosphorylation patterns between the parental NS5A and the adaptive mutation. Therefore, further genetic and biochemical studies will be required to clarify this important point.
While this paper was in preparation, Blight and coworkers (6) identified several cell culture-adaptive mutations too. Focusing their analysis on NS5A, they identified a total of 10 different mutations that were all located in the center of the molecule. Among these was the proline substitution for serine at position 2197 that we identified here as the most adaptive one. While this mutation reduced only NS5A hyperphosphorylation, it was completely blocked with an isoleucine substitution for serine at position 2204, and this mutation conferred the highest level of adaptation (6). Thus, NS5A hyperphosphorylation appears to be nonessential for HCV RNA replication in cell culture.
Cell culture adaptation by specific mutations in the genome has been described for several other viruses, too. In many cases, adaptation was used for the attenuation of a virus. For instance, with the Sindbis virus a selection procedure was used to isolate a noncytopathic replicon (15). This RNA harbored either one of two single amino acid substitutions in nonstructural protein 2 that reduced the level of RNA replication to 1% of that of the wild-type replicon. This reduction led to a loss of cytopathogenicity concomitant with a cell type restriction (1). Mutations conferring cell culture adaptation by enhancing virus growth have been described for HAV. While the parental virus has a slow-growth property, several cell culture-adapted isolates that replicate more efficiently and to higher titers have been described (e.g., see reference 46). The mutations primarily responsible for adaptation were identified in viral proteins 2B and 2C and in the 5' NTR (9, 18, 24), although other mutations acquired during adaptation could also contribute to efficient virus growth in cell culture (10, 11). However, the molecular basis for cell culture adaptation is not known.
The development of highly cell culture-adapted HCV replicons opens new avenues for studies of RNA replication, in particular with the help of reverse genetics. These analyses can now be performed in transient-transfection assays, circumventing the problem that, during selection of cells, the effect of a mutation to be studied is masked by second-site reversions or compensations. However, the use of selectable HCV replicons is still a valuable tool, in particular for mutants that replicate only poorly. Therefore, the combination of both assays should help to clarify the mechanism of HCV replication.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Ulrike Herian for excellent technical assistance and to Neera Borkakoti for help with three-dimensional modelling of NS3.
This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB490, Teilprojekt A2) and the European Community (QLK2-1999-00356).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute for Virology, Johannes-Gutenberg University Mainz, Obere Zahlbacher Strasse 67, 55131 Mainz, Germany. Phone: 49 6131 393 4451. Fax: 49 6131 393 5604. E-mail: bartnsch{at}mail.uni-mainz.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Agapov, E. V.,
I. Frolov,
B. D. Lindenbach,
B. M. Pragai,
S. Schlesinger, and C. M. Rice.
1998.
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression.
Proc. Natl. Acad. Sci. USA
95:12989-12994 |
| 2. |
Bartenschlager, R., and V. Lohmann.
2000.
Replication of hepatitis C virus.
J. Gen. Virol.
81:1631-1648 |
| 3. |
Bartenschlager, R.,
L. Ahlborn-Laake,
J. Mous, and H. Jacobsen.
1993.
Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions.
J. Virol.
67:3835-3844 |
| 4. |
Bartenschlager, R.,
L. Ahlborn-Laake,
J. Mous, and H. Jacobsen.
1994.
Kinetic and structural analyses of hepatitis C virus polyprotein processing.
J. Virol.
68:5045-5055 |
| 5. | Behrens, S. E., L. Tomei, and R. DeFrancesco. 1996. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 15:12-22[Medline]. |
| 6. |
Blight, K. J.,
A. A. Kolykhalov, and C. M. Rice.
2000.
Efficient initiation of HCV RNA replication in cell culture.
Science
290:1972-1974 |
| 7. |
Cheng, S.,
C. Fockler,
W. M. Barnes, and R. Higuchi.
1994.
Effective amplification of long targets from cloned inserts and human genomic DNA.
Proc. Natl. Acad. Sci. USA
91:5695-5699 |
| 8. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 9. |
Cohen, J. I.,
B. Rosenblum,
J. R. Ticehurst,
R. J. Daemer,
S. M. Feinstone, and R. H. Purcell.
1987.
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus.
Proc. Natl. Acad. Sci. USA
84:2497-2501 |
| 10. |
Day, S. P.,
P. Murphy,
E. A. Brown, and S. M. Lemon.
1992.
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells.
J. Virol.
66:6533-6540 |
| 11. | Emerson, S. U., Y. K. Huang, and R. H. Purcell. 1993. 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology 194:475-480[CrossRef][Medline]. |
| 12. | Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, N. Izumi, F. Marumo, and C. Sato. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Investig. 96:224-230. |
| 13. |
Enomoto, N.,
I. Sakuma,
Y. Asahina,
M. Kurosaki,
T. Murakami,
C. Yamamoto,
Y. Ogura,
N. Izumi,
F. Marumo, and C. Sato.
1996.
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
N. Engl. J. Med.
334:77-81 |
| 14. |
Failla, C.,
L. Tomei, and R. DeFrancesco.
1994.
Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.
J. Virol.
68:3753-3760 |
| 15. |
Frolov, I.,
E. Agapov,
T. A. Hoffman,
B. M. Pragai,
M. Lippa,
S. Schlesinger, and C. M. Rice.
1999.
Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells.
J. Virol.
73:3854-3865 |
| 16. | Gale, M. J., M. J. Korth, N. M. Tang, S. L. Tan, D. A. Hopkins, T. E. Dever, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227[CrossRef][Medline]. |
| 17. |
Gale, M. J.,
S. M. Blakely,
B. Kwieciszewski,
S.-L. Tan,
M. Dossett,
N. M. Tang,
M. J. Korth,
S. J. Polyak,
D. Gretch, and M. G. Katze.
1998.
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanism of kinase regulation.
Mol. Cell. Biol.
18:5208-5218 |
| 18. |
Graff, J.,
A. Normann,
S. M. Feinstone, and B. Flehmig.
1994.
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants.
J. Virol.
68:548-554 |
| 19. |
Grakoui, A.,
D. W. McCourt,
C. Wychowski,
S. M. Feinstone, and C. M. Rice.
1993.
A second hepatitis C virus-encoded proteinase.
Proc. Natl. Acad. Sci. USA
90:10583-10587 |
| 20. |
Grakoui, A.,
D. W. McCourt,
C. Wychowski,
S. M. Feinstone, and C. M. Rice.
1993.
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites.
J. Virol.
67:2832-2843 |
| 21. |
Hijikata, M.,
H. Mizushima,
T. Akagi,
S. Mori,
N. Kakiuchi,
N. Kato,
T. Tanaka,
K. Kimura, and K. Shimotohno.
1993.
Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.
J. Virol.
67:4665-4675 |
| 22. |
Hijikata, M.,
N. Kato,
Y. Ootsuyama,
M. Nakagawa, and K. Shimotohno.
1991.
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.
Proc. Natl. Acad. Sci. USA
88:5547-5551 |
| 23. | Ide, Y., A. Tanimoto, Y. Sasaguri, and R. Padmanabhan. 1997. Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytic subunit. Gene 201:151-158[CrossRef][Medline]. |
| 24. | Jansen, R. W., J. E. Newbold, and S. M. Lemon. 1988. Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology 163:299-307[CrossRef][Medline]. |
| 25. | Kaneko, T., Y. Tanji, S. Satoh, M. Hijikata, S. Asabe, K. Kimura, and K. Shimotohno. 1994. Production of two phsosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem. Biophys. Res. Commun. 205:320-326[CrossRef][Medline]. |
| 26. | Kim, D. W., Y. Gwack, J. H. Han, and J. Choe. 1995. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem. Biophys. Res. Commun. 215:160-166[CrossRef][Medline]. |
| 27. |
Lin, C.,
B. D. Lindenbach,
B. M. Pragai,
D. W. McCourt, and C. M. Rice.
1994.
Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.
J. Virol.
68:5063-5073 |
| 28. |
Lin, C.,
B. M. Pragai,
A. Grakoui,
J. Xu, and C. M. Rice.
1994.
Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.
J. Virol.
68:8147-8157 |
| 29. |
Lohmann, V.,
F. Körner,
A. Dobierzewska, and R. Bartenschlager.
2001.
Mutations in hepatitis C virus RNAs conferring cell culture adaptation.
J. Virol.
75:1437-1449 |
| 30. |
Lohmann, V.,
F. Körner,
J. O. Koch,
U. Herian,
L. Theilmann, and R. Bartenschlager.
1999.
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
Science
285:110-113 |
| 31. | Lohmann, V., F. Körner, U. Herian, and R. Bartenschlager. 1997. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71:8416-8428[Abstract]. |
| 32. |
Mizushima, H.,
M. Hijikata,
S. Asabe,
M. Hirota,
K. Kimura, and K. Shimotohno.
1994.
Two hepatitis C virus glycoprotein E2 products with different C termini.
J. Virol.
68:6215-6222 |
| 33. | Murphy, F. A., C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.). 1995. Classification and nomenclature of viruses: sixth report of the International Committee on Taxonomy of Viruses, p. 424-426. Springer Verlag, Vienna, Austria. |
| 34. |
Nakabayashi, H.,
K. Taketa,
K. Miyano,
T. Yamane, and J. Sato.
1982.
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
Cancer Res.
42:3858-3863 |
| 35. |
Pestova, T. V.,
I. N. Shatsky,
S. P. Fletcher,
R. J. Jackson, and C. U. Hellen.
1998.
A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs.
Genes Dev.
12:67-83 |
| 36. |
Pietschmann, T.,
V. Lohmann,
G. Rutter,
K. Kurpanek, and R. Bartenschlager.
2001.
Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.
J. Virol.
75:1252-1264 |
| 37. | Poynard, T., V. Ratziu, Y. Benhamou, P. Opolon, P. Cacoub, and P. Bedossa. 2000. Natural history of HCV infection. Best Practice Res. Clin. Gastroenterol. 14:211-228. |
| 38. |
Reed, K. E., and C. M. Rice.
1999.
Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine 2321.
J. Biol. Chem.
274:28011-28018 |
| 39. | Reed, K. E., and C. M. Rice. 2000. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242:55-84[Medline]. |
| 40. | Reed, K. E., J. Xu, and C. M. Rice. 1997. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J. Virol. 71:7187-7197[Abstract]. |
| 41. |
Suzich, J. A.,
J. K. Tamura,
H. F. Palmer,
P. Warrener,
A. Grakoui,
C. M. Rice,
S. M. Feinstone, and M. S. Collett.
1993.
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.
J. Virol.
67:6152-6158 |
| 42. | Tanji, Y., M. Hijikata, S. Satoh, T. Kaneko, and K. Shimotohno. 1995. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J. Virol. 69:1575-1581[Abstract]. |
| 43. | Tanji, Y., T. Kaneko, S. Satoh, and K. Shimotohno. 1995. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. 69:3980-3986[Abstract]. |
| 44. |
Tomei, L.,
C. Failla,
E. Santolini,
R. DeFrancesco, and N. LaMonica.
1993.
NS3 is a serine protease required for processing of hepatitis C virus polyprotein.
J. Virol.
67:4017-4026 |
| 45. |
Tsukiyama, K. K.,
N. Iizuka,
M. Kohara, and A. Nomoto.
1992.
Internal ribosome entry site within hepatitis C virus RNA.
J. Virol.
66:1476-1483 |
| 46. |
Venuti, A.,
C. Di Russo,
N. del Grosso,
A. M. Patti,
F. Ruggeri,
P. R. De Stasio,
M. G. Martiniello,
P. Pagnotti,
A. M. Degener,
M. Midulla,
A. Pana, and R. Perez-Bercoff.
1985.
Isolation and molecular cloning of a fast-growing strain of human hepatitis A virus from its double-stranded replicative form.
J. Virol.
56:579-588 |
| 47. |
Wang, C.,
P. Sarnow, and A. Siddiqui.
1993.
Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism.
J. Virol.
67:3338-3344 |
| 48. |
Yamashita, T.,
S. Kaneko,
Y. Shirota,
W. Qin,
T. Nomura,
K. Kobayashi, and S. Murakami.
1998.
RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region.
J. Biol. Chem.
273:15479-15486 |
This article has been cited by other articles: